Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Barbara Dietrich
Observed names:
B DIETRICH,
B. Dietrich
Institution:
Baxter (Austria)
Observed institutions:
University of Veterinary Medicine Vienna,
Baxter (Austria)
OpenAlex ID:
A5087269273
A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13
2012
·
Alexandra Schiviz
, Kuno Wuersch
, et al.
·
Blood
·
135
Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice
2012
·
Simon F. De Meyer
, Alexander S. Savchenko
, et al.
·
Blood
·
134
Various intracellular compartments cooperate in the release of nitric oxide from glycerol trinitrate in liver
2003
·
Andrey V Kozlov
, Barbara Dietrich
, et al.
·
British Journal of Pharmacology
·
74
PDF
A note on statistical analysis of organ weights in non-clinical toxicological studies
2009
·
Martin J. Wolfsegger
, Thomas Jaki
, et al.
·
Toxicology and Applied Pharmacology
·
42
Single dose human pharmacology of umespirone
1994
·
R.L. Holland
, K. Wesnes
, et al.
·
European Journal of Clinical Pharmacology
·
33
Preclinical assessment of a new recombinant ADAMTS‐13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura
2016
·
A. Kopić
, K. Benamara
, et al.
·
Journal of Thrombosis and Haemostasis
·
32
Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection
2009
·
Josef Mayrhofer
, Sogue Coulibaly
, et al.
·
Journal of Virology
·
29
Caroverine, a multifunctional drug with antioxidant functions
2003
·
Hans Nohl
, Werner Bieberschulte
, et al.
·
BioFactors
·
27
Preclinical safety and efficacy of a new recombinant FIX drug product for treatment of hemophilia B
2013
·
Barbara Dietrich
, Alexandra Schiviz
, et al.
·
International Journal of Hematology
·
16
PDF
Preclinical Testing of Human Recombinant von Willebrand Factor: ADAMTS13 Cleavage Capacity in Animals as Criterion for Species Suitability
2010
·
Eva-Maria Muchitsch
, Barbara Dietrich
, et al.
·
Seminars in Thrombosis and Hemostasis
·
13
Nonacog gamma, a novel recombinant factor IX with low factor IXa content for treatment and prophylaxis of bleeding episodes
2015
·
Peter L Turecek
, Brigitt Abbühl
, et al.
·
Expert Review of Clinical Pharmacology
·
11
Pharmacokinetics, disease-modifying activity, and safety of an experimental therapeutic targeting an immunological isoform of macrophage migration inhibitory factor, in rat glomerulonephritis
2017
·
Werner Höllriegl
, Alexander Bauer
, et al.
·
European Journal of Pharmacology
·
8
Preclinical safety and efficacy of the recombinant CR1 drug product CSL040 in rats and cynomolgus monkeys
2024
·
Tanja Ruthsatz
, Sandra Wymann
, et al.
·
Toxicology and Applied Pharmacology
·
4
Safety of Baxter’s Longer Acting rFVIII (BAX 855) After Repeated Application in Rats and Cynomolgus Monkeys
2011
·
Barbara Dietrich
, Margit Spatzenegger
, et al.
·
Blood
·
4
Age-gender study of SRA-333, a novel 5-HT antagonist
2005
·
A PATAT
, V PARKS
, et al.
·
Clinical Pharmacology & Therapeutics
·
4
Co-administration of CSL112 (apolipoprotein A-I [human]) with atorvastatin and alirocumab is not associated with increased hepatotoxic or toxicokinetic effects in rats
2021
·
Andrea Beyerle
, Brandon Greene
, et al.
·
Toxicology and Applied Pharmacology
·
3
PDF
Nonclinical Safety of SHP 826 (BAX 826), a Next Generation Extended Half-Life Recombinant Factor VIII Product
2016
·
Veronika Ehrlich
, Peter Leidenmuehler
, et al.
·
Blood
·
2
Preclinical Safety Pharmacology of Baxter’s Longer Acting rFVIII (BAX 855)
2011
·
Barbara Dietrich
, Susan Kubik
, et al.
·
Blood
·
2
Pre-clinical characterization of CSL040, a soluble complement receptor 1 (CR1) fragment
2025
·
Sandra Wymann
, Tanja Ruthsatz
, et al.
·
Immunobiology
·
1
Preclinical Safety of Baxter's Recombinant ADAMTS13
2012
·
Christina Piskernik
, Barbara Dietrich
, et al.
·
Blood
·
1
Absorption, Metabolism, Distribution, and Excretion of Longer Acting rFVIII (BAX 855) Following Intravenous Administration to Rats
2011
·
Reinhard Stidl
, Juergen Siekmann
, et al.
·
Blood
·
1
Preclinical Safety of Baxter's Recombinant Factor VIIa
2010
·
Barbara Dietrich
, Susan Kubik
, et al.
·
Blood
Toxico-Kinetics of Recombinant VWF In Non-Human Primates and Rabbits
2010
·
Eva-Maria Muchitsch
, Barbara Dietrich
, et al.
·
Blood
Preclinical Safety of Baxter's Recombinant Factor IX
2010
·
Barbara Dietrich
, Susan Kubik
, et al.
·
Blood
Weg mit der Mauer in Palästina
2007
·
Barbara Dietrich
·
Wissenschaft & Frieden
Show more works
View as search
Works count:
25
Citation count:
576
H-index:
11
I10-index:
11
Year
Topic
Type